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Background: Reconstruction of the thoracolumbar spine after tumor corpectomy can be accomplished
using either an expandable metallic cage (EC) or a polymethylmethacrylate (PMMA) cement spacer. Few
studies have compared the relative successes between these two forms of reconstructions in the management
of metastatic spine disease (MSD). The purpose of this study was to compare both the outcomes and costs
of EC and PMMA spacers in the treatment of MSD. We hypothesized that the rate of complications and
revision surgery when using PMMA spacers to reconstruct the spine after corpectomy for MSD would be
equivalent to use of an EC, with lower implant and operating room (OR) costs.
Methods: A single surgeon performed 65 vertebral corpectomies for MSD requiring anterior column
reconstruction from 2007–2014. Charts were retrospectively reviewed and no patients were excluded. All
resections were single-stage resections/reconstructions of the vertebral body through a posterior-only
approach. Outcomes evaluated included perioperative complications, intraoperative time, postoperative
survival, subsequent reoperations, and changes in radiographic spinal alignment.
Results: Thirty-six patients were treated with PMMA spacers; 29 were treated with EC. Baseline age, BMI,
comorbidities, and disease severity as measured by Tokuhashi scores were equivalent between treatment
groups. The cohorts had no significant differences in operative complications, blood loss, postoperative
survival, number of subsequent reoperations, or changes in radiographic alignment. PMMA patients had
a significantly shorter mean operative duration (328.6 vs. 241.1 min, P<0.001). Institutional implant cost
savings were $4,355 favoring the PMMA cohort ($75 for cement vs. $5,000 for cage). Mean OR time savings
were calculated to be $2,001 less for the PMMA cohort. Total cost minimization per PMMA case was thus
$6,356, which was robust in 2-way sensitivity analyses varying both implant costs and time costs by 30%.
Conclusions: In the largest series of posterior-only corpectomies for MSD reconstructed with PMMA,
PMMA intervertebral spacers provided equivalent stability and longevity to EC, at a fraction of the cost.
PMMA showed excellent durability while minimizing costs by $6,356 per case, an important consideration as
reimbursement pressures increasingly influence surgical decision making.
Keywords: Metastatic spine disease (MSD); corpectomy; expandable cage (EC); polymethylmethacrylate spacer
(PMMA spacer)
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Introduction

Methods

The vertebral column is the most common site of skeletal
metastasis. Metastatic spine disease (MSD) commonly
involves the vertebral body, and can cause structural
instability of the spinal column and epidural compression.
Patients can present with intractable pain, spinal instability,
and debilitating neurological deficits (1). Treatment for
MSD is typically palliative in nature, with the goal of
improving quality of life through restoration or preservation
of neurological function and easing of pain. Non-surgical
interventions include radiation therapy and percutaneous
vertebral augmentation; however, surgery may be necessary
for epidural compression or spinal instability. Surgical
management typically involves vertebral body resection
with anterior column reconstruction and posterior fixation.
Surgical access for MSD is often invasive, a consideration
not to be minimized in patients who frequently are
quite sick. Anterior approaches via trans-thoracic or
thoracoabdominal approaches have significant morbidity,
risk to visceral organs and vasculature, and can be
complicated by prior radiation therapy or surgery. Anterior
approaches also require a separate procedure for posterior
stabilization (1,2).
The posterior-only approach enables the surgeon to
gain access to the posterior elements and perform direct
spinal canal decompression, while still being able to work
within the vertebral body for anterior and middle column
decompression. Numerous studies have demonstrated that
vertebral body reconstruction can be predictably and safely
performed through a posterior-only lateral extracavitary
approach (3-5).
Vertebral body reconstruction can be accomplished with either
an expandable metal cage (EC) or a polymethylmethacrylate
(PMMA) spacer. PMMA, specifically, is relative easy to use,
inexpensive, and yields immediate stabilization. The cost of
ECs is notably higher than the cost of PMMA. However,
complications related to use of EC versus PMMA, and the
longevity of each type of interbody device, are relatively
unknown, particularly in the MSD patient population. Few
studies have compared the relative successes between these
two forms of reconstructions in the management of MSD.
In this study, we compared both the outcomes and costs
of EC and PMMA spacers in the treatment of MSD. We
hypothesized that the rate of complications and revision
surgery when using PMMA spacers to reconstruct the spine
after corpectomy for MSD would be equivalent to use of an
EC, with lower implant and operating room (OR) costs.

Sixty-five vertebral corpectomies for MSD required
anterior column reconstruction from 2007–2014, and
all were performed by the senior surgeon. Charts were
retrospectively reviewed and no patients were excluded.
All resections were performed via a posterior-only lateral
extracavitary approach as single-stage procedures. Typically
3 cm of the medial rib were removed bilaterally at the
affected level (if thoracic), which permitted sufficient
visualization and access to the anterior vertebral body. If
the rib was involved by the tumor, the affected portion was
removed.
Twenty-nine patients underwent reconstruction with
EC, and 36 patients received PMMA spacers. The decision
for use of an EC or use of PMMA was made by the senior
author; EC were utilized earlier in his practice, and he then
switched to using almost exclusively PMMA spacers after
initial good results were seen in patients. All EC implants
were Stryker VLift cages (Kalamazoo, MI, USA). Simplex
PMMA cement (Stryker, Kalamazoo, MI, USA) was used
in all cement cases. Surgical technique followed published
reports, and no lumbar nerve roots were sacrificed (3,5).
Intraoperative imaging was used for both EC and PMMA
placement, to insure correct placement and prevent
inappropriate cement extravasation.
In PMMA reconstructions, one or two short Kirschner
wires were inserted longitudinally into the vertebral bodies
above and below the corpectomy to help reinforce the
cement spacer and prevent it from migrating (Figure 1). In
order to do so, the wire was advanced through the inferior
endplate using a stout needle driver. The wire was then
aligned more perpendicular to the endplate and advanced
through the cephalad endplate. Cement was injected into
the corpectomy defect using a simple 50 ml syringe, after
allowing the cement viscosity to begin thickening so that
the PMMA could be easily contained in the vertebral defect.
Preoperative radiographs, computerized tomography
scans (CT), and magnetic resonance images (MRI) were
assessed to determine tumor extent using Tomita staging (6).
Spinal alignment preoperatively and postoperatively was
assessed using coronal and sagittal Cobb angle measurements.
Revised Tokuhashi scores were recorded to assess prognostic
indicators, and the Charlson Comorbidity Index was used
to quantify overall patient morbidity (7,8).
Postoperative radiographs were evaluated for implant
failure or progressive malalignment. Other outcomes
of interest included intraoperative time, perioperative
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Figure 1 PA and lateral postoperative radiographs demonstrating EC reconstruction (A,B) and PMMA reconstruction techniques (C,D).
PA, posterior-anterior; EC, expandable cage; PMMA, polymethylmethacrylate.

complications, postoperative survival, and subsequent
reoperations. Functional outcomes were assessed using
Oswestry disability index (ODI) scores.
A cost minimization economic model was employed.
Cost data were compiled using our institutional implant
pricing, as well as recent published estimates for the cost of
operative time in an orthopaedic OR setting (9). These OR
costs were derived using time-driven activity-based costing
(TDABC) methods, and were used as a proxy for our OR
costs as our institution was not able to provide us this data.
Two-way cost sensitivity analyses were then performed.
Statistical analysis included Student’s t-test for continuous
variables, z-tests for proportions, and a log rank test for
patient survival analysis. GraphPad (San Diego, CA, USA)
statistical software was utilized.
Results
There were no preoperative baseline differences in gender,
age at surgery, body mass index, smoking status, Charlson
Comorbidity Index, or revised Tokuhashi score between
the two treatment groups. The PMMA group did have a
slightly higher mean preoperative Tomita stage, indicating
more extensive spine involvement by tumor (4.89±1.30 vs.
4.10±1.18, P=0.001) (Table 1).
Patients reconstructed with PMMA had a shorter mean
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operative duration by 87 minutes (328.6 vs. 241.1 minutes,
P<0.001). No differences in estimated blood loss (EBL),
hospital length of stay, or intraoperative/perioperative
complications were found. Complications occurred in 34%
of the patients in the EC group and 33% in the PMMA
group (P=0.92) (Table 1). The most common complications
in both groups were wound infections requiring incisional
debridement (Table 2).
Postoperatively, there were no differences in the need for
subsequent spinal reoperation (24% in EC patient and 14%
in PMMA patients, P=0.46) (Table 1). The 7 reoperations in
the EC cohort included one cage revision for an endplate
fracture and implant subsidence that occurred 7 days after
the index operation. This patient developed an infection
after the revision and subsequently required an incisional
debridement as well. Four patients required further
decompression for recurrent tumor later in their disease
course, and two additional patients required incisional
debridement.
In the PMMA cohort, no patients required revision
surgery for cement spacer failure or extrusion. Two
patients required further decompression, one in the first
week after the index operation. This patient also required
incisional debridement after the second decompression
procedure. One other patient returned for instrumentation
extension and further decompression two years after the
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Table 1 Summary of patient characteristics and outcomes
Characteristics

Table 2 Complications of vertebral corpectomy for metastatic spine

Expandable
PMMA
P value
cages, N=29 spacers, N=36

Patient demographics
Sex

0.91

Disease

N

Expandable cages (N=29)
Surgical site infection (requiring incision/debridement)

3

Wound dehiscence (not requiring incision/debridement)

2

Cage subsidence

1

Male, n

15

17

–

Female, n

14

19

–

Age at surgery (yrs)

56.1±13.2

58.1±8.2

0.45

Hypokalemia

1

BMI

26.6±6.5

28.8±8.1

0.29

Pulmonary edema

1

Current smoker, n [%]

11 [38]

10 [28]

0.43

Delirium

1

Charlson comorbidity
index

7.3±1.8

7.5±1.3

0.57

Acute respiratory failure

1

Tomita tumor stage

4.10±1.18

4.89±1.30

Total

10

Revised Tokuhashi
score

9.8±2.1

9.6±2.1

0.001*
0.71

Perioperative parameters
Number of vertebral
levels fused

6.7±1.3

5.8±1.5

0.01*

Case length (min)

328.6±89.5

241.1±51.7

<0.001*

Estimated blood
loss (mL)

1,617±927

1,557±1,312

0.84

Length of postop
stay (days)

7.7±4.2

6.0±4.0

0.10

Comparison of outcomes
Duration of postop
survival (mos)

16.2±20.9

18.3±18.1

0.68

Postop complications,
n [%]

10 [34]

12 [33]

0.92

Spine reoperations,
n [%]

7 [24]

5 [14]

0.46

Pre-op ODI scores

47.1±22.8

45.2±21.2

0.79

Post-op ODI scores

23.9±18.6

36.0±30.0

0.33

Change in ODI scores

18.4±22.7

10.7±43.5

0.70

Pre-op coronal Cobb
angle (°)

−1.2±6.0

−0.8±4.2

0.75

Pre-op sagittal Cobb
angle (°)

14.2±11.9

4.3±19.6
−1.0±3.4

0.05*

Post-op coronal Cobb
angle (°)

0.1±2.1

Post-op sagittal Cobb
angle (°)

9.0±9.9

Change in coronal
Cobb angle (°)

1.4±5.6

−0.2±3.6

0.40

Change in sagittal
Cobb angle (°)

−5.2±10.0

−2.6±6.8

0.30

1.8±18.2

0.18
0.11

All values are mean ± SD, unless otherwise indicated; *, P value
<0.05 is significant. PMMA, polymethylmethacrylate.
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PMMA spacers (N=36)
Surgical site infection (requiring incision/debridement)

4

Deep vein thrombosis

3

Delirium

1

Acute respiratory failure

1

Hyponatremia

1

Acute kidney injury

1

Cardiogenic shock

1

Total

12

PMMA, polymethylmethacrylate.

index operation, and two other patients required incisional
debridement. No complications with cement displacement,
Kirschner wire migration, or thermal injury to neural
structures were noted.
There was no difference in patient survival between the
cohorts (16.2±20.9 months for EC, 18.3±18.1 months for
PMMA, P=0.68) (Figure 2). When analyzing radiographic
outcomes, the EC patients had a slightly larger mean preoperative sagittal Cobb angle (14.2° vs. 4.3°, P=0.05), but
the postoperative Cobb angle and the overall changes
in sagittal alignment were not different (Table 1). No
differences were seen in the preoperative or postoperative
ODI values between groups, nor when the changes in ODI
scores were compared between the cohorts (Table 1).
Because there were no significant differences in length
of stay or blood loss, we assumed that hospital boarding
costs and blood transfusion costs were similar between
the cohorts. We identified implant costs and operative
duration as the two primary cost variables between the EC
and PMMA cohorts. Our institutional cost for an EC was
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Duration of postop survival

Discussion

P value =0.322 for Log-rank test

Posterior-only approaches have been previously demonstrated
to allow for circumferential spinal decompression and
reconstruction through a single approach, with lower
complication rates and less cost than combined anteriorposterior approaches (2-5). We have sought to quantify the
longevity, complications, and relative costs of using EC and
PMMA spacers to achieve stability after metastatic tumor
corpectomy. This study is the largest series of posterioronly corpectomies for MSD with reconstruction using
PMMA, to the knowledge of the authors. In addition, this
is the first formal cost analysis comparing these two types of
corpectomy reconstructions.
While the indications for corpectomies in metastatic
disease patients are mainly palliative in nature, these
patients are now living longer after cancer diagnosis, leading
to an increasing incidence of MSD. In addition, patients
are living with metastatic disease for longer periods of
time, placing more biomechanical demands on their spinal
constructs (10). How to treat those MSD patients who need
surgery with the quickest, safest, and most cost-effective
techniques is thus an important question for the health care
system.
In our study, the effectiveness of treatment with either
EC or PMMA was essentially equivalent between the
treatments. There was no difference in postoperative
survival between the two treatment groups. There were
no disparities in radiographic alignment correction,
complication rates, or reoperation rates. Operative time in
the PMMA group was shown to be shorter compared to the
EC group. The senior author attributed this to the relative
ease of injecting PMMA into the corpectomy defect,
whereas maneuvering an EC into place can take additional
time to size the implant, as well as to resect additional bone
to allow maneuvering of the cage into place while retracting
and protecting neural structures.
Thus, our use of the cost minimization model was valid,
as our results indicated that the effectiveness of treatment
with either EC or PMMA were equivalent between
treatments. Cost minimization analysis is only valid when
this condition is met; otherwise, cost-effectiveness or costutility analyses must be performed (11,12). There are of
course institutional differences in the contracted cost of
EC implants, and in the cost of OR time. Our sensitivity
analyses still demonstrated cost superiority of PMMA when
varying these costs substantially. In aggregate, if all 65 cases
had been performed with EC reconstruction, a total implant

Percent survival

80
60
40
Cement

20

Cage
0
0

20

40
Months

60

80

Figure 2 Survival of patients with metastatic spine disease
reconstructed with expandable cages vs. cement spacers.

16000
14000

US dollars

12000
10000
EC

8000

PMMA

6000
4000
2000
0

Implant cost

OR time cost

Total cost

Figure 3 Cost minimization analysis of vertebral corpectomy,
comparing reconstruction using EC vs. cement spacers (PMMA).
Error bars represent 30% variation of each cost, demonstrating
that PMMA remains cost-superior after sensitivity analysis. EC,
expandable cage; PMMA, polymethylmethacrylate.

$4,430, while one bag of PMMA was $75. Thus, implant
cost savings were $4,355 favoring the PMMA cohort.
PMMA patients had a mean surgical duration of 87 minutes
less than EC patients. Using a literature-based OR time
cost of $23/min, mean OR time savings were $2,001 for
the PMMA cohort (9). Total cost minimization per PMMA
case was thus $6,356, which was robust in 2-way sensitivity
analyses varying both implant costs and time costs by 30%
(Figure 3).
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cost of $287,950 would have been incurred, versus just
$4,875 with the use of PMMA for all cases.
This study focused on patients with metastatic disease.
In reconstructions after resection of primary bone tumors
of the spine, the authors do advocate using an EC as
these patients are expected to have disease-free survival.
In addition, if a patient presented with severe kyphosis
from a metastatic lesion, using an EC can help to restore
alignment (13). These factors would favor selection of the
more expensive EC implant.
PMMA hardens via an exothermic process, so care must
be taken in the spine to not place the cement in contact
with the neural elements. In this series, we did not note any
complications from nerve root or spinal cord damage due
to heat injury. Our use of Kirschner wires placed into the
vertebrae above and below the corpectomy was a simple
way to help prevent dislodgement of the intercalary cement
block.
Eleraky et al. reported a series of 32 posterior-only
tumor resections for MSD, 16 of which were reconstructed
with ECs and 16 with PMMA. Similar to our series, no
differences in complications, stability, or reoperations
were noted. These authors noted a trend towards better
reduction of kyphosis in the EC patients, by approximately
5 degrees (14). Rajpal et al. reported on 37 thoracic and
lumbar MSD corpectomies, 5 of which were reconstructed
with PMMA. No PMMA patients and only 1 metallic cage
patient required revision surgery (15).
Limitations of this study include its single-center
design. Costs do likely vary between institutions and
between regions of the country. Moreover, cancer patients
are a heterogeneous population, and often many health
expenditures result from other aspects of their illness than
just MSD. Assignment of patients to each treatment cohort
was not randomized, and was at the discretion of the senior
surgeon. More of the EC cases were done earlier in the
senior surgeon’s experience, likely biasing the surgical
duration of the EC cases towards longer times. This
expected learning curve was included in our rationale for
the sensitivity analysis of the time cost, however. Despite
this selection bias, we do posit that there are actual time
savings using PMMA versus EC, given its ease of placement
in uncured form.
Additionally, costs will vary somewhat between hospitals,
based on vendor contracts. If a dedicated vertebroplastytype cement kit with an injector is used, rather than the
simple syringe we utilized, cement costs would also be
expected to increase relative to the EC cost. Finally,
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we acknowledge that postoperative life expectancy and
quality of life for patients with MSD likely improved
over the course of this study. More active patients who
are living longer would indeed place more stress on the
reconstruction, and yet we did not find that the PMMA
patients were experiencing failures or dislodgements.
In conclusion, the use of PMMA spacers is substantially
less expensive in patients with MSD than use of ECs, while
demonstrating equivalence in stability, spinal alignment,
and risk of implant-related complications.
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